Allergan plc is a global pharmaceutical company. The Company is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. The Company is also focused on developing, manufacturing and commercializing select over-the-counter (OTC) products. The Company markets a portfolio of products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories. The Company is also engaged in regenerative medicines business. The Company offers a range of dermal matrix products. The Company’s products include Botox, Juvederm, Linzess, Namenda, Restasis, Latisse, Teflaro, Lo Loestrin, Estrace, Viibryd, Asacol, Minastrin 24, Aczone, Ozurdex, Carafate and Namenda IR. Allergan selected Adexa for optimizing their production facilities and making their supply chain more efficient. Given the high asset intensive sites of the company as well as complexity of their operations Adexa was selected for its ability to model their environment very closely and scale to their operation and complexity of planning variety of resources and accuracy of the plans. In their industry mistakes are not an option.